siRNA, Anti-MAP1A, 2'-F/2'-OMe/2'-MOE/LNA/Ribo/Backbone-modified(CAT#: SIRGT11686WQ-2OMe)

The product SIRGT11686WQ-2OMe is a type of small interfering RNA (siRNA) that targets MAP1A gene and regulates the expression of gene. The siRNA interferes with the expression of MAP1A gene with complementary nucleotide sequences by degrading mRNA after transcription, preventing translation. The siRNA is designed with 2ʹ-O-methyl (2'-OMe) modification to provide increased stability, increased specificity and reduced immunogenicity. It has potential applications in RNA interference (RNAi) and gene therapy development.

Specifications
NCBI RefSeq NM_002373.5
Alternative Names MAP1L; MTAP1A
Related Diseases Colon Squamous Cell Carcinoma, Brain Cancer
Purification HPLC
Target Gene
Gene ID 4130
Uniprot ID P78559
Sub Cat Target Species Modification Scale  
SIRGT12686WQ-2F MAP1A Human 2ʹ-deoxy-2ʹ-fluoro (2'-F) Inquiry
SIRGT13686WQ-2MOE MAP1A Human 2'-O-methoxyethyl (2'-MOE) Inquiry
SIRGT14686WQ-LNA MAP1A Human Locked Nucleic Acid (LNA) Inquiry
SIRGT11686WQ-RB MAP1A Human Ribo-modified Inquiry
SIRGT12686WQ-BB MAP1A Human Backbone-modified Inquiry

Related Products